目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 56)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 61)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 TRANSFECTION TECHNOLOGIES MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 3 TRANSFECTION TECHNOLOGIES INDUSTRY SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1.1 Insights from primaries
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 TOP-DOWN APPROACH
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 8 MARKET: CAGR PROJECTIONS
FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 LIMITATIONS
2.7 RISK ANALYSIS
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 73)
FIGURE 11 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 12 TRANSFECTION TECHNOLOGIES INDUSTRY, BY METHOD, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 MARKET: GEOGRAPHIC ANALYSIS

4 PREMIUM INSIGHTS (Page No. - 77)
4.1 TRANSFECTION TECHNOLOGIES MARKET OVERVIEW
FIGURE 16 GROWING DEMAND FOR CELL AND GENE THERAPY TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES INDUSTRY, BY PRODUCT AND COUNTRY
FIGURE 17 KITS & REAGENTS HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 INDIA TO REGISTER HIGHEST CAGR IN GLOBAL MARKET OVER FORECAST PERIOD
4.4 MARKET SHARE, BY PRODUCT, 2022
FIGURE 19 KITS & REAGENTS HELD LARGEST SHARE OF PRODUCTS MARKET IN 2022

5 MARKET OVERVIEW (Page No. - 80)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 TRANSFECTION TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 TRANSFECTION TECHNOLOGIES INDUSTRY: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for cell and gene therapy
FIGURE 21 ESTIMATED CANCER CASELOAD, BY REGION
FIGURE 22 COMPARATIVE DATA FOR TOTAL NUMBER OF CLINICAL TRIALS
5.2.1.2 Rising research activity and R&D funding
5.2.1.3 Alliances for developing advanced therapeutic products
5.2.1.4 Expanded applications of transfection technologies
5.2.1.5 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 Limited efficiency of transfection methods
5.2.2.2 High cost of transfection products
5.2.2.3 Adoption of alternative methods
5.2.3 OPPORTUNITIES
5.2.3.1 Rising focus on personalized medicines
5.2.3.2 Growth opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Concern related to cytotoxicity and transfection in hard-to-transfect cells
5.2.4.2 Challenges associated with large-scale transfection processes
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 ECOSYSTEM/MARKET MAP
FIGURE 23 MARKET: ECOSYSTEM
5.4.1 PRODUCT VENDORS
TABLE 3 MARKET: PRODUCT VENDORS
5.4.2 END USERS
TABLE 4 MARKET: END USERS
5.4.3 REGULATORY BODIES
TABLE 5 MARKET: REGULATORY BODIES
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 24 MARKET: SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS OF MARKET: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PRICING ANALYSIS
TABLE 10 AVERAGE SELLING PRICE, BY COMPANY, 2022
TABLE 11 AVERAGE SELLING PRICE, BY REGION
5.9 TECHNOLOGY ANALYSIS
TABLE 12 MARKET: PROMINENT TECHNOLOGIES AND THEIR IMPACTS
5.10 PATENT ANALYSIS
FIGURE 26 PATENT APPLICATIONS FOR MARKET, JANUARY 2013-OCTOBER 2023
TABLE 13 MARKET: INDICATIVE LIST OF PATENTS
5.11 KEY CONFERENCES AND EVENTS, 2024-2025
TABLE 14 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024-2025
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27 REVENUE SHIFT AND NEW POCKETS FOR TRANSFECTION PRODUCT PROVIDERS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TRANSFECTION PRODUCTS
5.13.2 BUYING CRITERIA FOR TRANSFECTION PRODUCTS
FIGURE 29 KEY BUYING CRITERIA FOR END USERS
TABLE 15 KEY BUYING CRITERIA FOR END USERS

6 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (Page No. - 107)
6.1 INTRODUCTION
TABLE 16 TRANSFECTION TECHNOLOGIES INDUSTRY, BY PRODUCT, 2021-2028 (USD MILLION)
6.2 KITS & REAGENTS
6.2.1 KITS & REAGENTS SEGMENT TO HOLD LARGEST SHARE OF PRODUCTS MARKET
TABLE 17 TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 18 NORTH AMERICA: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 19 EUROPE: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 21 LATIN AMERICA: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA: TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 23 MIDDLE EAST: TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
6.3 EQUIPMENT
6.3.1 TECHNOLOGICAL DEVELOPMENTS AND RISING ADOPTION OF INNOVATIVE PRODUCTS TO BOOST MARKET GROWTH
TABLE 24 TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 25 NORTH AMERICA: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 26 EUROPE: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 28 LATIN AMERICA: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA: TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 30 MIDDLE EAST: TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION)

7 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD (Page No. - 115)
7.1 INTRODUCTION
TABLE 31 TRANSFECTION TECHNOLOGIES INDUSTRY, BY METHOD, 2021-2028 (USD MILLION)
7.2 PHYSICAL TRANSFECTION
TABLE 32 PHYSICAL TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 33 NORTH AMERICA: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 34 EUROPE: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 36 LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA: PHYSICAL TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 38 MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 39 PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
7.2.1 ELECTROPORATION
7.2.1.1 Growing demand for efficient cell transfection technologies to drive growth
TABLE 40 ELECTROPORATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 41 NORTH AMERICA: ELECTROPORATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 42 EUROPE: ELECTROPORATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 43 ASIA PACIFIC: ELECTROPORATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 44 LATIN AMERICA: ELECTROPORATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA: ELECTROPORATION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 46 MIDDLE EAST: ELECTROPORATION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.2.2 BIOLISTIC TRANSFECTION/GENE GUNS
7.2.2.1 Increasing focus on rapid and simple techniques to support market growth
TABLE 47 BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 48 NORTH AMERICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 49 EUROPE: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 51 LATIN AMERICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 53 MIDDLE EAST: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021-2028 (USD MILLION)
7.2.3 MICROINJECTION
7.2.3.1 Rising need for advanced cell transfection techniques to drive adoption
TABLE 54 MICROINJECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 55 NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 56 EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 57 ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 58 LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA: MICROINJECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 60 MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.2.4 OTHER PHYSICAL TRANSFECTION METHODS
TABLE 61 OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 62 NORTH AMERICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 63 EUROPE: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 64 ASIA PACIFIC: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 65 LATIN AMERICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 67 MIDDLE EAST: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)
7.3 BIOCHEMICAL-BASED TRANSFECTION
TABLE 68 BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 69 NORTH AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 70 EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 72 LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 73 MIDDLE EAST & AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 74 MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 75 BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
7.3.1 LIPOFECTION
7.3.1.1 High efficiency and compatibility to drive adoption
TABLE 76 LIPOFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 77 NORTH AMERICA: LIPOFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 78 EUROPE: LIPOFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: LIPOFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 80 LATIN AMERICA: LIPOFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 81 MIDDLE EAST & AFRICA: LIPOFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 82 MIDDLE EAST: LIPOFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.3.2 CALCIUM PHOSPHATE TRANSFECTION
7.3.2.1 Increasing R&D in cell-based therapies to drive market
TABLE 83 CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 84 NORTH AMERICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 85 EUROPE: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 86 ASIA PACIFIC: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 87 LATIN AMERICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 88 MIDDLE EAST & AFRICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 89 MIDDLE EAST: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.3.3 CATIONIC POLYMER TRANSFECTION
7.3.3.1 Adoption of innovative biochemical materials for transfection to accelerate growth
TABLE 90 CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 91 NORTH AMERICA: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 92 EUROPE: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 94 LATIN AMERICA: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA: CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 96 MIDDLE EAST: CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.3.4 DEAE-DEXTRAN TRANSFECTION
7.3.4.1 Simplicity, rapidity, and cost-effectiveness to support adoption
TABLE 97 DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 98 NORTH AMERICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 99 EUROPE: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 100 ASIA PACIFIC: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 101 LATIN AMERICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 103 MIDDLE EAST: DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.3.5 MAGNET-ASSISTED TRANSFECTION
7.3.5.1 Rising emphasis on innovative therapies for genetic disorders to drive adoption
TABLE 104 MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 105 NORTH AMERICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 106 EUROPE: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 107 ASIA PACIFIC: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 108 LATIN AMERICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 109 MIDDLE EAST & AFRICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 110 MIDDLE EAST: MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.3.6 DENDRIMER-MEDIATED TRANSFECTION
7.3.6.1 Non-biodegradable properties to restrain market growth
TABLE 111 DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 112 NORTH AMERICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 113 EUROPE: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 115 LATIN AMERICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 117 MIDDLE EAST: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
7.4 VIRAL-VECTOR BASED TRANSFECTION
7.4.1 TECHNOLOGICAL DEVELOPMENTS AND GROWING NEED FOR CELL & GENE THERAPY TO DRIVE MARKET
TABLE 118 VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 119 NORTH AMERICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 120 EUROPE: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 121 ASIA PACIFIC: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 122 LATIN AMERICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 124 MIDDLE EAST: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021-2028 (USD MILLION)

8 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION (Page No. - 160)
8.1 INTRODUCTION
TABLE 125 TRANSFECTION TECHNOLOGIES INDUSTRY, BY APPLICATION, 2021-2028 (USD MILLION)
8.2 THERAPEUTIC DELIVERY
TABLE 126 TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021-2028 (USD MILLION)
TABLE 127 NORTH AMERICA: MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 128 EUROPE: MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 130 LATIN AMERICA: MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021-2028 (USD MILLION)
TABLE 132 MIDDLE EAST: MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021-2028 (USD MILLION)
TABLE 133 TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
8.2.1 BIOTHERAPEUTICS
8.2.1.1 Rising need for cell and gene therapy to promote growth
TABLE 134 TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021-2028 (USD MILLION)
TABLE 135 NORTH AMERICA: MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 136 EUROPE: MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 138 LATIN AMERICA: MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021-2028 (USD MILLION)
TABLE 140 MIDDLE EAST: MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021-2028 (USD MILLION)
8.2.2 ELECTROIMMUNOTHERAPY
8.2.2.1 Increasing rate of chronic and immunological diseases to accelerate market growth
TABLE 141 TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
TABLE 142 NORTH AMERICA: MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 143 EUROPE: MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 144 ASIA PACIFIC: MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 145 LATIN AMERICA: MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 146 MIDDLE EAST & AFRICA: MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
TABLE 147 MIDDLE EAST: MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
8.2.3 ELECTROCHEMOTHERAPY
8.2.3.1 Need for advanced chemotherapy due to rising cancer incidence to drive market
TABLE 148 TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
TABLE 149 NORTH AMERICA: MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 150 EUROPE: MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 151 ASIA PACIFIC: MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 152 LATIN AMERICA: MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
TABLE 154 MIDDLE EAST: MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021-2028 (USD MILLION)
8.3 BIOMEDICAL RESEARCH
TABLE 155 TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 156 NORTH AMERICA: MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 157 EUROPE: MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 158 ASIA PACIFIC: MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 159 LATIN AMERICA: MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 160 MIDDLE EAST & AFRICA: MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 161 MIDDLE EAST: MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 162 TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
8.3.1 GENE & PROTEIN EXPRESSION STUDIES
8.3.1.1 Efforts to develop advanced gene therapy and genomic medicine promote growth
TABLE 163 TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 164 NORTH AMERICA: MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 165 EUROPE: MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 166 ASIA PACIFIC: MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 167 LATIN AMERICA: MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 169 MIDDLE EAST: MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021-2028 (USD MILLION)
8.3.2 CANCER RESEARCH
8.3.2.1 Increasing prevalence of cancer to propel market growth
TABLE 170 TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 171 NORTH AMERICA: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 172 EUROPE: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 173 ASIA PACIFIC: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 174 LATIN AMERICA: MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 175 MIDDLE EAST & AFRICA: MARKET FOR CANCER RESEARCH, BY REGION, 2021-2028 (USD MILLION)
TABLE 176 MIDDLE EAST: MARKET FOR CANCER RESEARCH, BY REGION, 2021-2028 (USD MILLION)
8.3.3 TRANSGENIC MODELS
8.3.3.1 Growing R&D activities and clinical studies to drive market
TABLE 177 TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021-2028 (USD MILLION)
TABLE 178 NORTH AMERICA: MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 179 EUROPE: MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 180 ASIA PACIFIC: MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 181 LATIN AMERICA: MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: MARKET FOR TRANSGENIC MODELS, BY REGION, 2021-2028 (USD MILLION)
TABLE 183 MIDDLE EAST: MARKET FOR TRANSGENIC MODELS, BY REGION, 2021-2028 (USD MILLION)
8.4 PROTEIN PRODUCTION
8.4.1 INCREASING INCIDENCE OF CHRONIC DISEASES AND DEMAND FOR PROTEIN THERAPEUTICS TO PROMOTE GROWTH
TABLE 184 TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021-2028 (USD MILLION)
TABLE 185 NORTH AMERICA: MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 186 EUROPE: MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 187 ASIA PACIFIC: MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 188 LATIN AMERICA: MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021-2028 (USD MILLION)
TABLE 190 MIDDLE EAST: MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021-2028 (USD MILLION)
8.5 CELL-BASED MICROARRAYS
8.5.1 INCREASING NEED FOR CELL-BASED THERAPIES TO DRIVE MARKET
TABLE 191 TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)
TABLE 192 NORTH AMERICA: MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 193 EUROPE: MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 194 ASIA PACIFIC: MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 195 LATIN AMERICA: MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)
TABLE 197 MIDDLE EAST: MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)

9 TRANSFECTION TECHNOLOGIES MARKET, BY END USER (Page No. - 195)
9.1 INTRODUCTION
TABLE 198 TRANSFECTION TECHNOLOGIES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE END-USER MARKET
TABLE 199 TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 200 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 201 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 202 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 203 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 204 MIDDLE EAST & AFRICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
TABLE 205 MIDDLE EAST: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
9.3 CROS & CDMOS
9.3.1 CONTRACT RESEARCH AND MANUFACTURING SECTOR TO SEE STRONG GROWTH
TABLE 206 TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021-2028 (USD MILLION)
TABLE 207 NORTH AMERICA: MARKET FOR CROS & CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 208 EUROPE: MARKET FOR CROS & CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 209 ASIA PACIFIC: MARKET FOR CROS & CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 210 LATIN AMERICA: MARKET FOR CROS & CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: MARKET FOR CROS & CDMOS, BY REGION, 2021-2028 (USD MILLION)
TABLE 212 MIDDLE EAST: MARKET FOR CROS & CDMOS, BY REGION, 2021-2028 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 INCREASING R&D AND GROWING TREND OF COLLABORATIVE RESEARCH TO PROMOTE MARKET GROWTH
TABLE 213 TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
TABLE 214 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 215 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 216 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 217 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
TABLE 219 MIDDLE EAST: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
9.5 OTHER END USERS
TABLE 220 TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
TABLE 221 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 222 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 223 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 224 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 225 MIDDLE EAST & AFRICA: MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
TABLE 226 MIDDLE EAST: MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

10 TRANSFECTION TECHNOLOGIES MARKET, BY REGION (Page No. - 210)
10.1 INTRODUCTION
TABLE 227 TRANSFECTION TECHNOLOGIES INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 30 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
TABLE 228 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 229 NORTH AMERICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 230 NORTH AMERICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 231 NORTH AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 232 NORTH AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 233 NORTH AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 234 NORTH AMERICA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 235 NORTH AMERICA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 236 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.2 US
10.2.2.1 US to dominate North American market
TABLE 237 US: INDICATIVE LIST OF THERAPIES APPROVED IN 2022
TABLE 238 US: INDICATIVE LIST OF PRODUCTS ANTICIPATED TO BE APPROVED IN 2023
TABLE 239 US: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 240 US: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 241 US: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 242 US: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 243 US: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 244 US: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 245 US: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 246 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Rising investments in R&D to drive market
TABLE 247 CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 248 CANADA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 249 CANADA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 250 CANADA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 251 CANADA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 252 CANADA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 253 CANADA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 254 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3 EUROPE
TABLE 255 EUROPE: INDICATIVE LIST OF THERAPIES APPROVED IN 2022
TABLE 256 EUROPE: INDICATIVE LIST OF PRODUCTS ANTICIPATED TO BE APPROVED IN 2023
10.3.1 EUROPE: RECESSION IMPACT
TABLE 257 EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 258 EUROPE: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 259 EUROPE: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 260 EUROPE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 261 EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 262 EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 263 EUROPE: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 264 EUROPE: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 265 EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Germany to hold largest share of European market till 2028
TABLE 266 GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 267 GERMANY: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 268 GERMANY: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 269 GERMANY: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 270 GERMANY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 271 GERMANY: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 272 GERMANY: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 273 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.3 UK
10.3.3.1 Increasing government funding for genomic projects to drive market
TABLE 274 UK: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 275 UK: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 276 UK: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 277 UK: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 278 UK: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 279 UK: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 280 UK: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 281 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Focus on collaborative development of advanced cell and gene therapies to promote market growth
TABLE 282 FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 283 FRANCE: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 284 FRANCE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 285 FRANCE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 286 FRANCE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 287 FRANCE: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 288 FRANCE: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 289 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Rising R&D investments and growing biotech industry to drive market
TABLE 290 ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 291 ITALY: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 292 ITALY: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 293 ITALY: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 294 ITALY: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 295 ITALY: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 296 ITALY: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 297 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Growing expansion of research centers to stimulate market growth
TABLE 298 SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 299 SPAIN: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 300 SPAIN: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 301 SPAIN: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 302 SPAIN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 303 SPAIN: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 304 SPAIN: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 305 SPAIN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 306 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 307 REST OF EUROPE: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 308 REST OF EUROPE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 309 REST OF EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 310 REST OF EUROPE: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 311 REST OF EUROPE: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 312 REST OF EUROPE: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 313 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 31 ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
TABLE 314 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 315 ASIA PACIFIC: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 316 ASIA PACIFIC: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 317 ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 318 ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 319 ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 320 ASIA PACIFIC: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 321 ASIA PACIFIC: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 322 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increasing R&D expenditure to propel market growth
TABLE 323 CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 324 CHINA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 325 CHINA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 326 CHINA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 327 CHINA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 328 CHINA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 329 CHINA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 330 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Booming CGT & RM sector to drive market
TABLE 331 JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 332 JAPAN: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 333 JAPAN: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 334 JAPAN: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 335 JAPAN: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 336 JAPAN: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 337 JAPAN: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 338 JAPAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Alliances and investments in research to drive market
TABLE 339 SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 340 SOUTH KOREA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 341 SOUTH KOREA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 342 SOUTH KOREA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 343 SOUTH KOREA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 344 SOUTH KOREA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 345 SOUTH KOREA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 346 SOUTH KOREA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.5 INDIA
10.4.5.1 Growing demand for advanced treatment solutions to propel market growth
TABLE 347 INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 348 INDIA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 349 INDIA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 350 INDIA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 351 INDIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 352 INDIA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 353 INDIA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 354 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.6 AUSTRALIA
10.4.6.1 Rising prevalence of chronic diseases and growing life science sector to drive market
TABLE 355 AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 356 AUSTRALIA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 357 AUSTRALIA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 358 AUSTRALIA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 359 AUSTRALIA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 360 AUSTRALIA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 361 AUSTRALIA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 362 AUSTRALIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 363 REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 364 REST OF ASIA PACIFIC: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 365 REST OF ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 366 REST OF ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 367 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 368 REST OF ASIA PACIFIC: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 369 REST OF ASIA PACIFIC: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 370 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 371 LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 372 LATIN AMERICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 373 LATIN AMERICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 374 LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 375 LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 376 LATIN AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 377 LATIN AMERICA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 378 LATIN AMERICA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 379 LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.2 BRAZIL
10.5.2.1 Brazil to hold largest share of LATAM market
TABLE 380 BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 381 BRAZIL: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 382 BRAZIL: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 383 BRAZIL: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 384 BRAZIL: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 385 BRAZIL: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 386 BRAZIL: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 387 BRAZIL: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Rising research activity to support market growth
TABLE 388 MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 389 MEXICO: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 390 MEXICO: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 391 MEXICO: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 392 MEXICO: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 393 MEXICO: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 394 MEXICO: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 395 MEXICO: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.4 ARGENTINA
10.5.4.1 Increasing government initiatives to drive market
TABLE 396 ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 397 ARGENTINA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 398 ARGENTINA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 399 ARGENTINA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 400 ARGENTINA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 401 ARGENTINA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 402 ARGENTINA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 403 ARGENTINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.5.5 REST OF LATIN AMERICA
TABLE 404 REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 405 REST OF LATIN AMERICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 406 REST OF LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 407 REST OF LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 408 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 409 REST OF LATIN AMERICA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 410 REST OF LATIN AMERICA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 411 REST OF LATIN AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 412 MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 413 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 414 MIDDLE EAST & AFRICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 415 MIDDLE EAST & AFRICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 416 MIDDLE EAST & AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 417 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 418 MIDDLE EAST & AFRICA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 419 MIDDLE EAST & AFRICA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 420 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.6.2 MIDDLE EAST
TABLE 421 MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 422 MIDDLE EAST: MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 423 MIDDLE EAST: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 424 MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 425 MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 426 MIDDLE EAST: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 427 MIDDLE EAST: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 428 MIDDLE EAST: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 429 MIDDLE EAST: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.6.2.1 GCC Countries
10.6.2.1.1 Increasing collaborations and partnerships to advance cell therapy to drive market
TABLE 430 GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 431 GCC COUNTRIES: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 432 GCC COUNTRIES: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 433 GCC COUNTRIES: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 434 GCC COUNTRIES: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 435 GCC COUNTRIES: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 436 GCC COUNTRIES: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 437 GCC COUNTRIES: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.6.2.2 Rest of the Middle East
TABLE 438 REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 439 REST OF MIDDLE EAST: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 440 REST OF MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 441 REST OF MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 442 REST OF MIDDLE EAST: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 443 REST OF MIDDLE EAST: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 444 REST OF MIDDLE EAST: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 445 REST OF MIDDLE EAST: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.6.3 AFRICA
10.6.3.1 Rising prevalence of HIV and cancer and growing precision medicine initiatives to fuel market growth
TABLE 446 AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 447 AFRICA: MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 448 AFRICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 449 AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 450 AFRICA: MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 451 AFRICA: MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 452 AFRICA: MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021-2028 (USD MILLION)
TABLE 453 AFRICA: MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 319)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.3 REVENUE SHARE ANALYSIS
11.4 MARKET SHARE ANALYSIS
FIGURE 34 TRANSFECTION TECHNOLOGIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 454 TRANSFECTION TECHNOLOGIES INDUSTRY: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT
TABLE 455 COMPANY FOOTPRINT
TABLE 456 COMPANY PRODUCT FOOTPRINT
TABLE 457 COMPANY REGION FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 36 TRANSFECTION TECHNOLOGIES INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES) (2022)
11.6.5 COMPETITIVE BENCHMARKING
TABLE 458 TRANSFECTION TECHNOLOGIES INDUSTRY: KEY STARTUPS/SMES
TABLE 459 TRANSFECTION TECHNOLOGIES INDUSTRY: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.7 COMPETITIVE SCENARIO
11.7.1 PRODUCT LAUNCHES
TABLE 460 TRANSFECTION TECHNOLOGIES INDUSTRY: KEY PRODUCT LAUNCHES, JANUARY 2020−DECEMBER 2023
11.7.2 DEALS
TABLE 461 TRANSFECTION TECHNOLOGIES INDUSTRY: KEY DEALS, JANUARY 2020− DECEMBER 2023
11.7.3 OTHER DEVELOPMENTS
TABLE 462 TRANSFECTION TECHNOLOGIES INDUSTRY: OTHER DEVELOPMENTS, JANUARY 2020−NOVEMBER 2023

12 COMPANY PROFILES (Page No. - 333)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 463 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
TABLE 464 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 465 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
TABLE 466 THERMO FISHER SCIENTIFIC INC.: DEALS
TABLE 467 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS
12.1.2 BIO-RAD LABORATORIES, INC.
TABLE 468 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
TABLE 469 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
12.1.3 QIAGEN
TABLE 470 QIAGEN: BUSINESS OVERVIEW
FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
TABLE 471 QIAGEN: PRODUCTS OFFERED
12.1.4 MERCK KGAA
TABLE 472 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
TABLE 473 MERCK KGAA: PRODUCTS OFFERED
TABLE 474 MERCK KGAA: DEALS
TABLE 475 MERCK KGAA: OTHER DEVELOPMENTS
12.1.5 SARTORIUS AG (POLYPLUS)
TABLE 476 SARTORIUS AG (POLYPLUS): BUSINESS OVERVIEW
FIGURE 41 SARTORIUS AG (POLYPLUS): COMPANY SNAPSHOT (2022)
TABLE 477 SARTORIUS AG (POLYPLUS): PRODUCTS OFFERED
TABLE 478 SARTORIUS AG (POLYPLUS): PRODUCT LAUNCHES
TABLE 479 SARTORIUS AG (POLYPLUS): DEALS
12.1.6 LONZA
TABLE 480 LONZA: BUSINESS OVERVIEW
FIGURE 42 LONZA: COMPANY SNAPSHOT (2022)
TABLE 481 LONZA: PRODUCTS OFFERED
TABLE 482 LONZA: PRODUCT LAUNCHES
TABLE 483 LONZA: DEALS
12.1.7 F. HOFFMANN-LA ROCHE LTD.
TABLE 484 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
TABLE 485 F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERED
12.1.8 AGILENT TECHNOLOGIES, INC.
TABLE 486 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
TABLE 487 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 488 AGILENT TECHNOLOGIES, INC.: DEALS
12.1.9 MAXCYTE
TABLE 489 MAXCYTE: BUSINESS OVERVIEW
FIGURE 45 MAXCYTE: COMPANY SNAPSHOT (2022)
TABLE 490 MAXCYTE: PRODUCTS OFFERED
TABLE 491 MAXCYTE: PRODUCT LAUNCHES
TABLE 492 MAXCYTE: DEALS
12.1.10 REVVITY
TABLE 493 REVVITY: BUSINESS OVERVIEW
FIGURE 46 REVVITY: COMPANY SNAPSHOT (2022)
TABLE 494 REVVITY: PRODUCTS OFFERED
TABLE 495 REVVITY: DEALS
TABLE 496 REVVITY: OTHER DEVELOPMENTS
12.1.11 TAKARA BIO INC.
TABLE 497 TAKARA BIO INC.: BUSINESS OVERVIEW
FIGURE 47 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
TABLE 498 TAKARA BIO INC.: COMPANY OVERVIEW
12.1.12 PROMEGA CORPORATION
TABLE 499 PROMEGA CORPORATION: BUSINESS OVERVIEW
TABLE 500 PROMEGA CORPORATION: PRODUCTS OFFERED
12.1.13 DANAHER CORPORATION
TABLE 501 DANAHER CORPORATION: BUSINESS OVERVIEW
AFIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 502 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 503 DANAHER CORPORATION: PRODUCT LAUNCHES
TABLE 504 DANAHER CORPORATION: DEALS
TABLE 505 DANAHER CORPORATION: OTHER DEVELOPMENTS
12.2 OTHER PLAYERS
12.2.1 BOC SCIENCES
TABLE 506 BOC SCIENCES: COMPANY OVERVIEW
12.2.2 RJH BIOSCIENCES
TABLE 507 RJH BIOSCIENCES: COMPANY OVERVIEW
12.2.3 SYNVOLUX
TABLE 508 SYNVOLUX: COMPANY OVERVIEW
12.2.4 ALTOGEN BIOSYSTEMS
TABLE 509 ALTOGEN BIOSYSTEMS: COMPANY OVERVIEW
12.2.5 BIOIVT
TABLE 510 BIOIVT: COMPANY OVERVIEW
12.2.6 INCELLA GMBH
TABLE 511 INCELLA GMBH (SCREENFECT): COMPANY OVERVIEW
12.2.7 INVIVOGEN
TABLE 512 INVIVOGEN: COMPANY OVERVIEW
12.2.8 PHOREUS BIOTECH
TABLE 513 PHOREUS BIOTECH: COMPANY OVERVIEW
12.2.9 STEMCELL TECHNOLOGIES
TABLE 514 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
12.2.10 EZ BIOSYSTEMS
TABLE 515 EZ BIOSYSTEMS: COMPANY OVERVIEW
12.2.11 OZ BIOSCIENCES
TABLE 516 OZ BIOSCIENCES: COMPANY OVERVIEW
12.2.12 CHEMICELL GMBH
TABLE 517 CHEMICELL GMBH: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 390)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS